These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11604272)

  • 1. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.
    Kapsi SG; Ayres JW
    Int J Pharm; 2001 Oct; 229(1-2):193-203. PubMed ID: 11604272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
    Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
    AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot-melt extrusion for enhanced delivery of drug particles.
    Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
    J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
    Hong JY; Kim JK; Song YK; Park JS; Kim CK
    J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals.
    Brewster ME; Verreck G; Chun I; Rosenblatt J; Mensch J; Van Dijck A; Noppe M; Ariën A; Bruining M; Peeters J
    Pharmazie; 2004 May; 59(5):387-91. PubMed ID: 15212307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
    Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
    Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.
    Fadke J; Desai J; Thakkar H
    AAPS PharmSciTech; 2015 Dec; 16(6):1434-44. PubMed ID: 25991065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole.
    Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P
    Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
    Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
    Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.
    Janssens S; Roberts C; Smith EF; Van den Mooter G
    Int J Pharm; 2008 May; 355(1-2):100-7. PubMed ID: 18191508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.